Insider Transactions in Q1 2024 at Inari Medical, Inc. (NARI)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 18
2024
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
40,000
-1.93%
|
$1,640,000
$41.22 P/Share
|
|
Mar 12
2024
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,000
-1.58%
|
$252,000
$42.25 P/Share
|
|
Mar 12
2024
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+3.07%
|
$0
$0.46 P/Share
|
|
Feb 16
2024
|
Hill, Mitch C. Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,812
+7.47%
|
-
|
|
Feb 16
2024
|
Thomas Tu Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,812
+4.25%
|
-
|
|
Feb 16
2024
|
Andrew Hykes President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
40,786
+7.94%
|
-
|
|
Jan 01
2024
|
Andrew Hykes President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,063
-0.24%
|
$196,032
$64.92 P/Share
|
|
Jan 01
2024
|
William Hoffman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,197
-0.11%
|
$140,608
$64.92 P/Share
|
|
Jan 01
2024
|
Thomas Tu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,783
-0.19%
|
$114,112
$64.92 P/Share
|
|
Jan 01
2024
|
Hill, Mitch C. Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,742
-0.34%
|
$111,488
$64.92 P/Share
|